Point72 Hong Kong LTD Xencor Inc Transaction History

Point72 Hong Kong LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$19.74 - $29.01 $127,777 - $187,781	6,473 New	6,473 $177,000
Q1 2022 May 16, 2022	SELL	$26.68 - $41.63 $27,133 - $42,337	-1,017 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$33.67 - $43.44 $34,242 - $44,178	1,017 New	1,017 $41,000
Q3 2021 Nov 15, 2021	SELL	$30.65 - $35.68 $113,006 - $131,552	-3,687 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$34.33 - $44.68 $126,574 - $164,735	3,687 New	3,687 $127,000
Q4 2018 Feb 14, 2019	SELL	$32.39 - $42.05 $4,631 - $6,013	-143 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$35.69 - $47.65 $5,103 - $6,813	143 New	143 $6,000

199

73.7M

1.7K

4.2K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $940M
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.